Radiopharmaceutical developer Ionetix is investing $25.8 million into the Lansing, MI region, additionally creating 53 new jobs.
Ionetix specializes in the production and distribution of radiopharmaceuticals and targeted alpha therapy agents for diagnostic imaging and cancer treatment.
The company has announced that it will be investing in renovations and improvements, as well as expanding its existing Lansing-area facilities. The company aims to increase its supply chain distribution of radiopharmaceutical products, according to a statement.
In addition, Ionetix’s expansion has received support through the Michigan Economic Development Corporation (MEDC) via a Michigan Business Development Program performance-based grant of $750,000.
